Replies to post #2673 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

NB2 is a CBD analogue

'A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests.'

So maybe that will avoid Any patent infringement issues

[cjarmstrong]

From what I understand, GW is lobbying to have CBD reclassified as a schedule IV drug. In the SD bill, I believe the 'FDA approved only' wording was ultimately removed. I'm not sure about what's happened/happening in other states.